187 related articles for article (PubMed ID: 24188322)
1. Probucol inhibits the initiation of atherosclerosis in cholesterol-fed rabbits.
Niimi M; Keyamura Y; Nozako M; Koyama T; Kohashi M; Yasufuku R; Yoshikawa T; Fan J
Lipids Health Dis; 2013 Nov; 12():166. PubMed ID: 24188322
[TBL] [Abstract][Full Text] [Related]
2. Add-on effect of probucol in atherosclerotic, cholesterol-fed rabbits treated with atorvastatin.
Keyamura Y; Nagano C; Kohashi M; Niimi M; Nozako M; Koyama T; Yasufuku R; Imaizumi A; Itabe H; Yoshikawa T
PLoS One; 2014; 9(5):e96929. PubMed ID: 24810608
[TBL] [Abstract][Full Text] [Related]
3. Probucol suppresses macrophage infiltration and MMP expression in atherosclerotic plaques of WHHL rabbits.
Li S; Liang J; Niimi M; Bilal Waqar A; Kang D; Koike T; Wang Y; Shiomi M; Fan J
J Atheroscler Thromb; 2014; 21(7):648-58. PubMed ID: 24584175
[TBL] [Abstract][Full Text] [Related]
4. Demonstration of an add-on effect of probucol and cilostazol on the statin-induced anti-atherogenic effects.
Wang Y; Bai L; Lin Y; Guan H; Zhu N; Chen Y; Li Y; Gao S; Zhao S; Fan J; Liu E
Histol Histopathol; 2014 Dec; 29(12):1593-600. PubMed ID: 25078428
[TBL] [Abstract][Full Text] [Related]
5. Simultaneous intake of oat bran and atorvastatin reduces their efficacy to lower lipid levels and atherosclerosis in LDLr-/- mice.
Eussen SR; Rompelberg CJ; Andersson KE; Klungel OH; Hellstrand P; Oste R; van Kranen H; Garssen J
Pharmacol Res; 2011 Jul; 64(1):36-43. PubMed ID: 21371558
[TBL] [Abstract][Full Text] [Related]
6. Probucol and cilostazol exert a combinatorial anti-atherogenic effect in cholesterol-fed rabbits.
Chen Y; Zhao S; Huang B; Wang Y; Li Y; Waqar AB; Liu R; Bai L; Fan J; Liu E
Thromb Res; 2013 Nov; 132(5):565-71. PubMed ID: 24090606
[TBL] [Abstract][Full Text] [Related]
7. Probucol alleviates atherosclerosis and improves high density lipoprotein function.
Zhong JK; Guo ZG; Li C; Wang ZK; Lai WY; Tu Y
Lipids Health Dis; 2011 Nov; 10():210. PubMed ID: 22078494
[TBL] [Abstract][Full Text] [Related]
8. Effect of atorvastatin therapy on oxidant-antioxidant status and atherosclerotic plaque formation.
Sezer ED; Sozmen EY; Nart D; Onat T
Vasc Health Risk Manag; 2011; 7():333-43. PubMed ID: 21731885
[TBL] [Abstract][Full Text] [Related]
9. Effects of atorvastatin and/or probucol on recovery of atherosclerosis in high-fat-diet-fed apolipoprotein E-deficient mice.
Guo X; Wang L; Xia X; Wang P; Li X
Biomed Pharmacother; 2019 Jan; 109():1445-1453. PubMed ID: 30551396
[TBL] [Abstract][Full Text] [Related]
10. Probucol-Oxidized Products, Spiroquinone and Diphenoquinone, Promote Reverse Cholesterol Transport in Mice.
Yakushiji E; Ayaori M; Nishida T; Shiotani K; Takiguchi S; Nakaya K; Uto-Kondo H; Ogura M; Sasaki M; Yogo M; Komatsu T; Lu R; Yokoyama S; Ikewaki K
Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):591-7. PubMed ID: 26848156
[TBL] [Abstract][Full Text] [Related]
11. Chlorogenic acid protects against atherosclerosis in ApoE-/- mice and promotes cholesterol efflux from RAW264.7 macrophages.
Wu C; Luan H; Zhang X; Wang S; Zhang X; Sun X; Guo P
PLoS One; 2014; 9(9):e95452. PubMed ID: 25187964
[TBL] [Abstract][Full Text] [Related]
12. Lipid-lowering activity of atorvastatin and lovastatin in rodent species: triglyceride-lowering in rats correlates with efficacy in LDL animal models.
Krause BR; Newton RS
Atherosclerosis; 1995 Oct; 117(2):237-44. PubMed ID: 8801869
[TBL] [Abstract][Full Text] [Related]
13. Probucol treatment attenuates the aortic atherosclerosis in Watanabe heritable hyperlipidemic rabbits.
Oshima R; Ikeda T; Watanabe K; Itakura H; Sugiyama N
Atherosclerosis; 1998 Mar; 137(1):13-22. PubMed ID: 9568732
[TBL] [Abstract][Full Text] [Related]
14. Combined use of probucol and cilostazol with atorvastatin attenuates atherosclerosis in moderately hypercholesterolemic rabbits.
Wang Y; Bai L; Lin Y; Chen Y; Guan H; Zhu N; Li Y; Gao S; Sun L; Zhao S; Fan J; Liu E
Lipids Health Dis; 2015 Jul; 14():82. PubMed ID: 26220196
[TBL] [Abstract][Full Text] [Related]
15. All-trans retinoic acid effectively reduces atheroma plaque size in a rabbit model of high-fat-induced atherosclerosis.
Zarei L; Bahrami M; Farhad N; Froushani SMA; Abbasi A
Adv Clin Exp Med; 2018 Dec; 27(12):1631-1636. PubMed ID: 30048051
[TBL] [Abstract][Full Text] [Related]
16. Pitavastatin: novel effects on lipid parameters.
Chapman MJ
Atheroscler Suppl; 2011 Nov; 12(3):277-84. PubMed ID: 22152282
[TBL] [Abstract][Full Text] [Related]
17. [Effects of atorvastatin, fluvastatin, pravastatin, and simvastatin on endothelial function, lipid peroxidation, and aortic atherosclerosis in hypercholesterolemic rabbits].
Jorge PA; Almeida EA; Ozaki MR; Jorge M; Carneiro A
Arq Bras Cardiol; 2005 Apr; 84(4):314-9. PubMed ID: 15880205
[TBL] [Abstract][Full Text] [Related]
18. Endoglin as a possible marker of atorvastatin treatment benefit in atherosclerosis.
Rathouska J; Vecerova L; Strasky Z; Slanarova M; Brcakova E; Mullerova Z; Andrys C; Micuda S; Nachtigal P
Pharmacol Res; 2011 Jul; 64(1):53-9. PubMed ID: 21440631
[TBL] [Abstract][Full Text] [Related]
19. Effects of immunomodulatory drugs on plasma inflammatory markers in a rabbit model of atherosclerosis.
Houssen ME; Haron MM; Metwally SS; Ibrahim TM
J Physiol Biochem; 2011 Mar; 67(1):115-20. PubMed ID: 20960084
[TBL] [Abstract][Full Text] [Related]
20. Dual effects of the antioxidant agents probucol and carvedilol on proliferative and fatty lesions in hypercholesterolemic rabbits.
Donetti E; Soma MR; Barberi L; Paoletti R; Fumagalli R; Roma P; Catapano AL
Atherosclerosis; 1998 Nov; 141(1):45-51. PubMed ID: 9863537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
